HAMBURG, Germany and OXFORD, England, February 8 /PRNewswire-FirstCall/
-- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that Jörn
Aldag, President & CEO, will present at the BIO CEO & Investor Conference
in New York.
Date: Tuesday, 12 February 2008
Time: 11.45 am EST (05.45 pm CET/04.45 pm GMT)
Location: Waldorf-Astoria, New York City
The presentation slides will be available on the Evotec website at
http://www.evotec.com - Investors shortly after the presentation.
Contact:
Evotec AG
Anne Hennecke
SVP, Investor Relations & Corporate Communications
Phone: +49(0)40-56081-286
Fax: +49(0)40-56081-333
E-Mail: anne.hennecke@evotec.com
'/>"/>SOURCE Evotec AG Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 Related biology technology :1.
Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia2.
Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 2013.
Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York4.
Evotec AG: R&D Update on 16 October 2007 Live on the Internet5.
Evotec Reports Third Quarter 2007 Results6.
Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board7.
Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis8.
Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 20079.
Avicena Group to Present at Noble Financial Conference10.
Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA11.
Strategic Diagnostics to Present at Two Upcoming Investor Conferences